Sign In
Buy IVRO
$0.0750
+0 (+0%)
At Close: Jun 03, 2026
Continuing the Cause; Humane Global Animal Welfare
09:00am, Tuesday, 05'th May 2026
Placentia, California--(Newsfile Corp. - May 5, 2026) - Today, InVitro International (OTCQB: IVRO) reported FY '26 Q2 sales of $206,840, up 5.3 % over the same period in FY '25. YTD sales of $389,440
InVitro International & the World's Animals Look Forward to 2026
09:00am, Wednesday, 11'th Feb 2026
Placentia, California--(Newsfile Corp. - February 11, 2026) - Today, InVitro International (OTCQB: IVRO) reported undefined quarter FY '26 sales of
Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains
09:00am, Tuesday, 09'th Dec 2025
Placentia, California--(Newsfile Corp. - December 9, 2025) - Today, InVitro International (OTCQB: IVRO) reported FY '25 sales of $878,937, up 8.3% over FY '24. Net income of $121,980 advanced 14.3% fo
IVRO's Q3 Packed with Positives; Sales, Profits, and U.S. Government/Global Support for Animal Welfare
09:00am, Tuesday, 05'th Aug 2025
Placentia, California--(Newsfile Corp. - August 5, 2025) - Today, InVitro International (OTCQB: IVRO) reported FY '25, Q3 sales of $234,430, up 39.7% over the same period in FY '24. YTD sales of $675,
IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances
09:00am, Tuesday, 04'th Feb 2025
Placentia, California--(Newsfile Corp. - February 4, 2025) - InVitro International (OTCQB: IVRO) today announced a solid 15.4% sales advance in Q1 of FY '25, totaling $244,143; this compares favorably
IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization
09:00am, Tuesday, 14'th Jan 2025
Placentia, California--(Newsfile Corp. - January 14, 2025) - InVitro International (OTCQB: IVRO) previously revealed its strategic intent to accelerate organic growth by pursuing mergers and acquisiti
InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities
09:00am, Wednesday, 04'th Dec 2024
Placentia, California--(Newsfile Corp. - December 4, 2024) - Today InVitro International (OTCQB: IVRO) announced FY '24 sales of $811,290, up 2.4% vs. FY '23. Net income of $106,704 soared over the pr
InVitro International Engages Askew Kabala and Company, Inc. to Further Advance Its Corporate Growth Plan
09:00am, Tuesday, 03'rd Sep 2024
Placentia, California--(Newsfile Corp. - September 3, 2024) - Today InVitro International (OTCQB: IVRO) is pleased to announce that it has engaged Askew Kabala and Company, Inc. as consultant to the c
InVitro International Progresses with Growth Strategies and Continues Profitability
09:00am, Wednesday, 31'st Jul 2024
Placentia, California--(Newsfile Corp. - July 31, 2024) - Today, InVitro International (OTCQB: IVRO) announced third quarter FY '24 sales of $167,850, off 16% vs the same quarter last year. Net income
InVitro International Reports Positive First Half and Second Quarter FY '24 Results; Also Planning an OTC Markets Uplisting
09:00am, Thursday, 02'nd May 2024
Placentia, California--(Newsfile Corp. - May 2, 2024) - Today, InVitro International (OTC Pink: IVRO), announced second quarter FY '24 sales of $210,615, up 5.8% compared to $199,090 for the same peri
InVitro International Sees Real Positives in Start to FY '24
09:00am, Wednesday, 14'th Feb 2024
Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technol
InVitro International Announces Fiscal Year End 2023 and Continues Positives
09:00am, Monday, 13'th Nov 2023
Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technol
IVRO Announces Fiscal Q #3 2023 Results While Continuing M&A Strategy to Make Non-Animal Testing Famous
09:00am, Wednesday, 09'th Aug 2023
Placentia, California--(Newsfile Corp. - August 9, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 20
